 3. FAP patients who used NSAIDs non-steroidal anti-inflammatory drugs or aspirin three or more times a week within 6 months of randomization. 4. FAP patients with diabetes mellitus. 5. Pregnant or breast-feeding patients. 6. Patients with abnormal results of serum laboratory tests renal function and liver function test and significant infectious or respiratory diseases. 